Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

By Boulton David W.   Li Li   Frevert Ernst U.   Tang Angela   Castaneda Lorna   Vachharajani Nimish N.   Kornhauser David M.   Patel Chirag G.  

Clinical Pharmacokinetics, Vol. 50, Iss. 4, 2011-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

By Weil Angelika  

Clinical Pharmacokinetics, Vol. 49, Iss. 9, 2010-09 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite

Effects of Hepatic or Renal Impairment on the Pharmacokinetics of Aripiprazole

By Mallikaarjun Suresh  

Clinical Pharmacokinetics, Vol. 47, Iss. 8, 2008-01 ,pp. : 533-542

Adis International

Access to resources Recommend Favorite

Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist

By Bauman John  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 662-671

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment

By Kearney Brian P.   Yale Kitty   Shah Jaymin   Zhong Lijie   Flaherty John F.  

Clinical Pharmacokinetics, Vol. 45, Iss. 11, 2006-01 ,pp. : 1115-1124

Adis International

Access to resources Recommend Favorite